Narrative Update • Jun 26
Have your own idea? Try our Stock Screener
Dutch (AEX) Biotech Industry Analysis
UpdatedJul 09, 2026
DataAggregated Company Financials
Companies3
- 7D3.8%
- 3M0.5%
- 1Y15.1%
- YTD-8.2%
In the last week, the Biotech industry is up 3.0%, with all of the companies up. This takes the industry's 12 month performance to a gain of 17%. In the next few years, earnings are forecast to decline by 19% annually.
Industry Valuation and Performance
Has the Dutch Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Thu, 09 Jul 2026 | €2.7b | €1.4b | €489.9m | 42.8x | 5.5x | 2x |
| Sat, 06 Jun 2026 | €2.4b | €1.4b | €489.8m | 38.5x | 5x | 1.8x |
| Mon, 04 May 2026 | €2.6b | €1.4b | €313.1m | 210.4x | 8.4x | 1.8x |
| Wed, 01 Apr 2026 | €2.7b | €1.4b | €309.5m | 201.9x | 8.9x | 1.9x |
| Fri, 27 Feb 2026 | €2.9b | €1.4b | €307.3m | 1465x | 9.3x | 2x |
| Sun, 25 Jan 2026 | €3.1b | €593.4m | -€456,031,866.20 | 3547.3x | -6.8x | 5.3x |
| Tue, 23 Dec 2025 | €2.9b | €595.3m | -€456,029,879.80 | 3087.3x | -6.3x | 4.8x |
| Thu, 20 Nov 2025 | €2.7b | €600.9m | -€456,023,958.80 | 2874.8x | -6x | 4.6x |
| Sat, 18 Oct 2025 | €2.8b | €566.8m | -€307,958,400.00 | n/a | -9.1x | 4.9x |
| Mon, 15 Sep 2025 | €2.7b | €565.2m | -€307,918,220.00 | n/a | -8.7x | 4.7x |
| Wed, 13 Aug 2025 | €2.5b | €566.7m | -€316,041,940.00 | n/a | -7.8x | 4.4x |
| Fri, 11 Jul 2025 | €2.4b | €562.4m | -€211,970,348.80 | n/a | -11.1x | 4.2x |
| Sun, 08 Jun 2025 | €2.4b | €569.6m | -€212,290,691.20 | n/a | -11.3x | 4.2x |
| Tue, 06 May 2025 | €2.2b | €550.8m | -€210,367,523.50 | n/a | -10.3x | 3.9x |
| Thu, 03 Apr 2025 | €2.0b | €549.6m | -€11,445,585.90 | n/a | -176.1x | 3.7x |
| Sat, 01 Mar 2025 | €2.3b | €550.3m | -€18,411,685.30 | n/a | -124.1x | 4.2x |
| Mon, 27 Jan 2025 | €2.1b | €532.4m | -€77,598,101.30 | n/a | -26.9x | 3.9x |
| Wed, 25 Dec 2024 | €2.3b | €535.0m | -€77,760,290.60 | n/a | -29.8x | 4.3x |
| Fri, 22 Nov 2024 | €2.1b | €532.7m | -€77,614,142.00 | n/a | -26.4x | 3.8x |
| Sun, 20 Oct 2024 | €2.4b | €516.9m | €19.2m | 58.4x | 124.2x | 4.6x |
| Tue, 17 Sep 2024 | €2.3b | €510.8m | €19.5m | 56.9x | 116.2x | 4.4x |
| Thu, 15 Aug 2024 | €1.9b | €513.4m | €19.4m | 46.3x | 100.2x | 3.8x |
| Sat, 13 Jul 2024 | €2.2b | €480.5m | €20.8m | 53.7x | 105.2x | 4.6x |
| Mon, 10 Jun 2024 | €2.2b | €482.8m | €20.7m | 53.3x | 104.7x | 4.5x |
| Wed, 08 May 2024 | €2.4b | €471.7m | €20.9m | 58.5x | 114.7x | 5.1x |
| Fri, 05 Apr 2024 | €2.6b | €466.1m | -€39,612,789.40 | n/a | -66.5x | 5.7x |
| Sun, 03 Mar 2024 | €3.0b | €441.6m | -€50,629,354.00 | n/a | -60.1x | 6.9x |
| Tue, 30 Jan 2024 | €3.4b | €745.9m | -€199,721,382.00 | n/a | -16.8x | 4.5x |
| Thu, 28 Dec 2023 | €3.3b | €740.8m | -€199,207,500.00 | n/a | -16.8x | 4.5x |
| Sat, 25 Nov 2023 | €3.2b | €744.0m | -€199,531,709.00 | n/a | -15.8x | 4.3x |
| Mon, 23 Oct 2023 | €3.1b | €754.9m | -€199,135,876.00 | n/a | -15.4x | 4x |
| Wed, 20 Sep 2023 | €3.3b | €753.2m | -€199,001,248.00 | n/a | -16.8x | 4.4x |
| Fri, 18 Aug 2023 | €3.4b | €749.9m | -€200,603,918.00 | n/a | -16.9x | 4.5x |
| Sun, 16 Jul 2023 | €3.5b | €727.3m | -€211,406,747.00 | n/a | -16.4x | 4.8x |
Price to Earnings Ratio
-16.4x
Current Industry PE
- There are only 3 companies in the Dutch Biotechs industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
- Total earnings for the Biotechs industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 23% per year.
- This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Industry Trends
Which industries have driven the changes within the Dutch Healthcare industry?
| NL Market | -2.76% | |
| Healthcare | 0.88% | |
| Biotech | 3.82% | |
| Biotech | 3.82% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| LKFT Lakefront Biotherapeutics | €26.80 | 3.1% +€52.7m | 5.8% | PE3.6x | |
| PHARM Pharming Group | €1.26 | 4.8% +€40.6m | 42.2% | PE82.1x | |
| VVY Vivoryon Therapeutics | €1.26 | 17.8% +€5.6m | -13.1% | PB7.9x |